483
Leila Chaychi, M.D.FDA 483 - Leila Chaychi, M.D. - October 22, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Leila Chaychi, M.D., a clinical investigator in San Carlos, CA, revealed significant deficiencies in the conduct of clinical investigations. Observations included failures to adhere to investigational plans, enroll eligible subjects, and properly document informed consent. These issues indicate a lack of control over study conduct and subject protection.
Open in Dashboard
ID · 5ef7f15c-cff3-47a6-9d41-4ca32fa5eef3